Home › NDC Lookup › RxCUI directory › RxCUI 312563

Povidone-iodine 0.1 MG/MG Topical Ointment — RxCUI 312563

RxNorm drug concept · Semantic clinical drug
RxCUI 312563 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312563
Official namePovidone-iodine 0.1 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspovidone-iodine 10 % Topical Ointment; povidone-iodine 10 % (equal to 1 % available iodine) Topical Ointment
FDA products mapped7
Package NDCs mapped7
Reported Medicaid activity (SDUD)16 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Povidone-Iodine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Povidone-iodine is an antiseptic — it kills bacteria on the skin. You'll find it in a lot of different products: surgical scrubs, skin prep solutions and swabs used before procedur...
  • What is povidone-iodine actually used for?
  • The standard topical products are for external skin use only — keep them away from your eyes, ears, and mouth. That said, the 3M Skin and Nasal Antiseptic is specifically labeled f...
  • For first-aid use at home, you should not use povidone-iodine on a wound for more than 7 days unless a doctor or dentist tells you it's okay. If your wound isn't improving after a...
📖 Read our full Povidone-Iodine guide →

🕸️ Concept Web — How Povidone-iodine 0.1 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Povidone-iodine 0.1 MG/MG Topical Ointment RxCUI 312563

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Povidone-iodine 8611
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dermawound 1432881
    • Efodine 216867
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Povidone-iodine Topical Ointment 374506
    • Povidone-iodine Topical Product 1161091
    • Povidone-iodine Topical Ointment [Dermawound] 1432883
    • Povidone-iodine Topical Ointment [Efodine] 367366
    • Dermawound Topical Product 1432884
    • Efodine Topical Product 1173228
    • Topical Ointment 316985
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Povidone-iodine 0.1 MG/MG SCDC · 340051
  • Povidone-iodine Topical Ointment SCDF · 374506
  • Povidone-iodine Topical Product SCDG · 1161091

Brand-Name Concepts

  • Povidone-iodine 0.1 MG/MG Topical Ointment [Dermawound] SBD · 1432885
  • Povidone-iodine 0.1 MG/MG Topical Ointment [Efodine] SBD · 211103
  • Povidone-iodine 0.1 MG/MG [Dermawound] SBDC · 1432882
  • Povidone-iodine 0.1 MG/MG [Efodine] SBDC · 571565
  • Povidone-iodine Topical Ointment [Dermawound] SBDF · 1432883
  • Povidone-iodine Topical Ointment [Efodine] SBDF · 367366
  • Dermawound Topical Product SBDG · 1432884
  • Efodine Topical Product SBDG · 1173228
  • Dermawound BN · 1432881
  • Efodine BN · 216867

📦 FDA Products & Package NDCs

7 products · 7 package NDCs
7 package NDCs map to RxCUI 312563 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00536-1271-80 1 TUBE in 1 BOX (0536-1271-80) / 28.4 g in 1 TUBE First Aid Antiseptic Rugby Laboratories 2020-11-03
39892-0820-01 1 g in 1 PACKET (39892-0820-1) MediChoice Povidone-Iodine O&M HALYARD, INC. 2019-03-04
57554-0110-06 1 TUBE in 1 CARTON (57554-110-06) / 179 g in 1 TUBE DermaWound Wound Care Progressive Doctors, LLC 2013-04-08
59050-0269-00 1 g in 1 POUCH (59050-269-00) Maokang 10 Povidone Iodine Changzhou Maokang Medical Products Co., Ltd 2023-08-30
69396-0112-20 1 TUBE in 1 BOX (69396-112-20) / 28.3 g in 1 TUBE Povidone Iodine Trifecta Pharmaceuticals USA LLC 2022-12-23
81526-0002-01 100 POUCH in 1 BOX (81526-002-01) / 1 g in 1 POUCH TM Titus Medical Povidone Iodine Titus Medical LLC 2021-06-21
81584-1102-01 1 TUBE in 1 CARTON (81584-1102-1) / 28.35 g in 1 TUBE Povidone Iodine Dr Radows 2021-06-30
Observed labelers: Changzhou Maokang Medical Products Co., Ltd (1) · Dr Radows (1) · O&M HALYARD, INC. (1) · Progressive Doctors, LLC (1) · Rugby Laboratories (1) · Titus Medical LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.